Barry Quart is a biopharmaceutical executive with a doctorate, known for his leadership in guiding biotech firms through clinical development.
Barry Quart is a biopharmaceutical executive with a doctorate, known for his leadership in guiding biotech firms through clinical development and commercialization. He is currently the CEO of Connect Biopharma, a company focused on asthma and COPD treatments. Previously, he was associated with Heron Therapeutics, Inc., which specializes in pain management and chemotherapy-induced nausea treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library